Thymic carcinoma patients with myasthenia gravis exhibit better prognoses
详细信息 查看全文
- 作者：Wenya Li ; Zhifeng Miao ; Xudong Liu…
- 关键词：Thymic carcinoma ; Myasthenia gravis ; Complete resection ; Prognosis
- 刊名：International Journal of Clinical Oncology
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：21
- 期：1
- 页码：75-80
- 全文大小：536 KB
- 参考文献：1.Müller-Hermelink H, Engel P, Harris N et al (2004) Tumours of the thymus. In: Travis WD, Brambilla E, Müller-Helmelink HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart. WHO classification of tumors series. IARC Press, Lyon, France, pp 145–151
2.Filosso PL, Guerrera F, Rendina AE et al (2014) Outcome of surgically resected thymic carcinoma: a multicenter experience. Lung Cancer 83(2):205–210. doi:10.1016/j.lungcan.2013.11.015 CrossRef PubMed
3.Chalabreysse L, Etienne-Mastroianni B, Adeleine P et al (2004) Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology (Oxf) 44(4):367–374. doi:10.1111/j.1365-2559.2004.01796.x CrossRef
4.Blumberg D, Burt ME, Bains et al (1998) Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 115(2):303–308 (discussion 308–309) CrossRef PubMed
5.Kondo K, Monden Y (2003) Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76(3):878–884 (discussion 884–875) CrossRef PubMed
6.Detterbeck F, Youssef S, Ruffini E et al (2011) A review of prognostic factors in thymic malignancies. J Thorac Oncol 6(7 suppl 3):S1698–S1704. doi:10.1097/JTO.0b013e31821e7b12 CrossRef PubMed
7.Modh A, Rimner A, Allen PK et al (2014) Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: a retrospective multicenter study. Am J Clin Oncol. doi:10.1097/COC.0000000000000024 PubMed
8.Hosaka Y, Tsuchida M, Toyabe S et al (2010) Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg 89(3):912–917. doi:10.1016/j.athoracsur.2009.11.057 CrossRef PubMed
9.Weksler B, Dhupar R, Parikh V et al (2013) Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 95(1):299–303. doi:10.1016/j.athoracsur.2012.09.006 CrossRef PubMed
10.Weissferdt A, Moran CA (2012) Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 138(1):103–114. doi:10.1309/AJCP88FZTWANLRCB CrossRef PubMed
11.Spillane J, Higham E, Kullmann DM (2012) Myasthenia gravis. BMJ 345:e8497. doi:10.1136/bmj.e8497 CrossRef PubMed
12.Angelini C (2011) Diagnosis and management of autoimmune myasthenia gravis. Clin Drug Invest 31(1):1–14. doi:10.2165/11584740-000000000-00000 CrossRef
13.Drachman DB (1994) Myasthenia gravis. N Engl J Med 330(25):1797–1810. doi:10.1056/NEJM199406233302507 CrossRef PubMed
14.Skeie GO, Romi F (2008) Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 15(10):1029–1033. doi:10.1111/j.1468-1331.2008.02242.x CrossRef PubMed
15.Venuta F, Anile M, Diso D et al (2010) Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 37(1):13–25. doi:10.1016/j.ejcts.2009.05.038 CrossRef PubMed
16.Zhao Y, Zhao H, Hu D et al (2013) Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. Ann Thorac Surg 96(3):1019–1024. doi:10.1016/j.athoracsur.2013.04.078 CrossRef PubMed
17.Liu HC, Hsu WH, Chen YJ et al (2002) Primary thymic carcinoma. Ann Thorac Surg 73(4):1076–1081CrossRef PubMed
18.Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48-49:143–148CrossRef PubMed
19.Suster S, Rosai J (1991) Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer (Phila) 67(4):1025–1032CrossRef
20.Filosso PL, Ruffini E, Lausi PO et al (2014) Historical perspectives: the evolution of the thymic epithelial tumors staging system. Lung Cancer 83(2):126–132. doi:10.1016/j.lungcan.2013.09.013 CrossRef PubMed
21.Koga K, Matsuno Y, Noguchi M et al (1994) A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44(5):359–367CrossRef PubMed
22.Okereke IC, Kesler KA, Freeman RK et al (2012) Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg 93(5):1668–1672. doi:10.1016/j.athoracsur.2012.01.014 (discussion 1672–1673) CrossRef PubMed
23.Ogawa K, Toita T, Uno T et al (2002) Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer (Phila) 94(12):3115–3119. doi:10.1002/cncr.10588 CrossRef
24.Huang J, Detterbeck FC, Wang Z et al (2011) Standard outcome measures for thymic malignancies. J Thorac Oncol 6(7 suppl 3):S1691–S1697. doi:10.1097/JTO.0b013e3182254ac1 CrossRef PubMed
25.Yano M, Sasaki H, Yokoyama T et al (2008) Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol 3(3):265–269. doi:10.1097/JTO.0b013e3181653c71 CrossRef PubMed
26.Park IK, Kim YT, Jeon JH et al (2013) Importance of lymph node dissection in thymic carcinoma. Ann Thorac Surg 96(3):1025–1032. doi:10.1016/j.athoracsur.2013.04.057 (Discussion 1032) CrossRef PubMed
27.Masaoka A, Monden Y, Nakahara K et al (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer (Phila) 48(11):2485–2492CrossRef
28.Tsuchiya R, Koga K, Matsuno Y et al (1994) Thymic carcinoma: proposal for pathological TNM and staging. Pathol Int 44(7):505–512CrossRef PubMed
29.Berardi R, De Lisa M, Pagliaretta S et al (2014) Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. Cancer Treat Rev 40(4):495–506. doi:10.1016/j.ctrv.2013.11.003 CrossRef PubMed - 作者单位：Wenya Li (1)
Zhifeng Miao (2)
Xudong Liu (3)
Qigang Zhang (1)
Lei Sun (1)
Peiwen Li (1)
Wenke Liu (1)
Lin Zhang (1)
1. Department of Thoracic Surgery, The First Affiliated Hospital of China Medical University, No. 155 North Nanjing Street, Shenyang, 110001, Liaoning Province, China
2. Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning Province, China
3. Department of Rheumatology and Immunology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning Province, China - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Oncology
Surgical Oncology
Radiotherapy
Diagnostic Radiology
Internal Medicine
Pathology - 出版者：Springer Japan
- ISSN：1437-7772
文摘
Background Thymic carcinoma is an aggressive mediastinal neoplasm with a poor prognosis, but the factors that contribute to its prognosis are not completely understood. Myasthenia gravis (MG) can coexist with thymic carcinoma with low incidence, but the effect MG has on thymic carcinoma prognosis is unknown. Here, we investigated the prognostic factors of thymic carcinoma and the influence of MG on patients with this disease.